Diagnostic accuracy of early biomarkers for acute coronary syndrome (ACS) (2012) Elli Gerakopoulou 10.15131/shef.data.11913540.v1 https://orda.shef.ac.uk/articles/poster/Diagnostic_accuracy_of_early_biomarkers_for_acute_coronary_syndrome_ACS_2012_/11913540 <p>Background: Current practice for suspected ACS involves troponin testing 10-12 hours after symptom onset to diagnose myocardial infarction (MI).</p> <p>Aim: To estimate the diagnostic accuracy of early biomarkers for MI to determine if an earlier, accurate decision was possible<br></p> <p>Rationale: Early discharge of patients with no or low risk of ACS will result in cost savings and reduced healthcare and patient burden.</p> 2020-02-28 12:17:04 Acute Coronary Syndrome myocardial infarction Health Economics